Department of General Surgery, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang, 330006, Jiangxi Province, China.
World J Surg Oncol. 2023 Jul 4;21(1):196. doi: 10.1186/s12957-023-03083-w.
Surgery is becoming less invasive as technology advances. Natural orifice specimen extraction surgery (NOSES) ushered in a new era of minimally invasive techniques. At the same time, NOSES is gaining popularity in the world. With their distinct advantages, surgical robots have advanced the development of NOSES. The aim of current study was to compare the short-term outcomes between robotic-assisted NOSES and laparoscopic-assisted NOSES for the treatment of middle rectal cancer.
Patients with middle rectal cancer who underwent robotic-assisted or laparoscopic-assisted NOSES at the First Affiliated Hospital of Nanchang University between January 2020 and June 2022 had their clinicopathological data collected retrospectively. 46 patients were enrolled in the study: 23 in the robotic group and 23 in the laparoscopic group. Short-term outcomes and postoperative anal function in the two groups were compared.
There was no significant difference in the clinicopathological data between the two groups. The robotic group had less intraoperative blood loss (p = 0.04), less postoperative abdominal drainage (p = 0.02), lower postoperative white blood cell counts (p = 0.024) and C-reactive protein levels (p = 0.017), and shorter catheter removal time when compared to the laparoscopic group (p = 0.003). Furthermore, there were no significant difference in mean operative time (159 ± 31 min vs 172 ± 41 min) between the robotic and laparoscopic groups (p = 0.235), but time to naked the rectum (86.4 ± 20.9 min vs. 103.8 ± 31.5 min p = 0.033) and time of digestive tract reconstruction (15.6 ± 3.88 min vs. 22.1 ± 2.81 min p < 0.01) in the robotic group were significantly shorter than laparoscopic group. The robotic group had lower postoperative Wexner scores than the laparoscopic group.
This research reveals that combining a robotic surgical system and NOSES results in superior outcomes, with short-term outcomes preferable to laparoscopic-assisted NOSES.
随着技术的进步,外科手术变得越来越微创。经自然腔道取标本手术(NOSES)开创了微创技术的新纪元。与此同时,NOSES 在世界范围内越来越受欢迎。手术机器人具有独特的优势,推动了 NOSES 的发展。本研究旨在比较机器人辅助 NOSES 与腹腔镜辅助 NOSES 治疗中直肠肿瘤的短期疗效。
回顾性收集 2020 年 1 月至 2022 年 6 月南昌大学第一附属医院行机器人辅助或腹腔镜辅助 NOSES 的中直肠患者的临床病理资料。共纳入 46 例患者:机器人组 23 例,腹腔镜组 23 例。比较两组患者的短期疗效和术后肛门功能。
两组患者的临床病理资料无统计学差异。机器人组术中出血量更少(p=0.04),术后腹腔引流更少(p=0.02),术后白细胞计数(p=0.024)和 C 反应蛋白水平(p=0.017)更低,导尿管拔除时间更短(p=0.003)。两组的平均手术时间无统计学差异(159±31min 比 172±41min,p=0.235),但裸肛时间(86.4±20.9min 比 103.8±31.5min,p=0.033)和消化道重建时间(15.6±3.88min 比 22.1±2.81min,p<0.01)机器人组明显短于腹腔镜组。机器人组术后 Wexner 评分低于腹腔镜组。
本研究表明,机器人手术系统联合 NOSES 可获得更好的效果,短期疗效优于腹腔镜辅助 NOSES。